Concepts (233)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Alcoholism | 12 | 2023 | 1906 | 2.380 |
Why?
|
| Ethanol | 13 | 2022 | 1342 | 1.720 |
Why?
|
| gamma-Aminobutyric Acid | 5 | 2021 | 1121 | 1.160 |
Why?
|
| Gyrus Cinguli | 5 | 2023 | 1091 | 1.160 |
Why?
|
| Brain | 28 | 2023 | 26385 | 1.130 |
Why?
|
| Breathing Exercises | 3 | 2020 | 53 | 1.010 |
Why?
|
| Yoga | 4 | 2020 | 253 | 0.930 |
Why?
|
| Brain Chemistry | 4 | 2015 | 981 | 0.930 |
Why?
|
| Thalamus | 3 | 2020 | 1023 | 0.840 |
Why?
|
| Magnetic Resonance Spectroscopy | 10 | 2015 | 3760 | 0.830 |
Why?
|
| Alcohol Drinking | 4 | 2023 | 3966 | 0.810 |
Why?
|
| Religion | 2 | 2022 | 356 | 0.810 |
Why?
|
| Frontal Lobe | 5 | 2014 | 1406 | 0.800 |
Why?
|
| Sex Characteristics | 4 | 2020 | 2585 | 0.770 |
Why?
|
| Residential Treatment | 1 | 2021 | 111 | 0.730 |
Why?
|
| Hospitals, Psychiatric | 1 | 2021 | 332 | 0.700 |
Why?
|
| Emotions | 4 | 2022 | 2661 | 0.680 |
Why?
|
| Impulsive Behavior | 4 | 2015 | 316 | 0.680 |
Why?
|
| Depressive Disorder, Major | 7 | 2020 | 4644 | 0.660 |
Why?
|
| Adolescent Development | 3 | 2014 | 278 | 0.660 |
Why?
|
| Phosphorus | 3 | 2008 | 338 | 0.580 |
Why?
|
| Adolescent Behavior | 2 | 2021 | 1151 | 0.580 |
Why?
|
| Drug Tolerance | 3 | 2004 | 376 | 0.540 |
Why?
|
| Students | 2 | 2018 | 1654 | 0.540 |
Why?
|
| Marijuana Abuse | 4 | 2015 | 403 | 0.530 |
Why?
|
| Substance-Related Disorders | 4 | 2022 | 4258 | 0.500 |
Why?
|
| Amnesia, Retrograde | 1 | 2014 | 20 | 0.490 |
Why?
|
| Alcohol-Induced Disorders | 1 | 2014 | 26 | 0.480 |
Why?
|
| Glutamic Acid | 3 | 2019 | 1169 | 0.470 |
Why?
|
| Drinking Behavior | 1 | 2014 | 103 | 0.470 |
Why?
|
| Universities | 1 | 2018 | 956 | 0.440 |
Why?
|
| Glutamine | 2 | 2019 | 578 | 0.440 |
Why?
|
| Alcohol-Induced Disorders, Nervous System | 1 | 2012 | 11 | 0.440 |
Why?
|
| Septal Nuclei | 2 | 2023 | 85 | 0.400 |
Why?
|
| Animals, Newborn | 6 | 2004 | 2726 | 0.400 |
Why?
|
| Adolescent | 24 | 2022 | 85781 | 0.390 |
Why?
|
| Amygdala | 6 | 2023 | 1315 | 0.390 |
Why?
|
| Space Perception | 1 | 2014 | 475 | 0.390 |
Why?
|
| Stroop Test | 1 | 2010 | 62 | 0.380 |
Why?
|
| Magnetic Resonance Imaging | 21 | 2023 | 35421 | 0.380 |
Why?
|
| Marijuana Smoking | 2 | 2011 | 253 | 0.360 |
Why?
|
| Inpatients | 1 | 2021 | 2518 | 0.360 |
Why?
|
| Facial Expression | 1 | 2014 | 508 | 0.350 |
Why?
|
| Nerve Net | 1 | 2022 | 2174 | 0.350 |
Why?
|
| Prefrontal Cortex | 5 | 2021 | 2147 | 0.350 |
Why?
|
| Aging | 9 | 2019 | 8664 | 0.350 |
Why?
|
| Aspartic Acid | 3 | 2019 | 576 | 0.350 |
Why?
|
| Cognition Disorders | 3 | 2015 | 4043 | 0.330 |
Why?
|
| Cytidine Diphosphate Choline | 1 | 2008 | 30 | 0.330 |
Why?
|
| Cannabis | 1 | 2015 | 439 | 0.330 |
Why?
|
| Cerebral Cortex | 5 | 2019 | 5708 | 0.320 |
Why?
|
| Male | 56 | 2023 | 350118 | 0.310 |
Why?
|
| Receptors, N-Methyl-D-Aspartate | 2 | 2004 | 895 | 0.310 |
Why?
|
| Central Nervous System Depressants | 4 | 2002 | 167 | 0.300 |
Why?
|
| Young Adult | 19 | 2022 | 56430 | 0.300 |
Why?
|
| Female | 56 | 2023 | 380194 | 0.290 |
Why?
|
| Methadone | 2 | 2006 | 306 | 0.270 |
Why?
|
| GABA-A Receptor Agonists | 2 | 2004 | 84 | 0.270 |
Why?
|
| GABA Agonists | 2 | 2004 | 111 | 0.260 |
Why?
|
| Nerve Fibers, Myelinated | 1 | 2011 | 957 | 0.250 |
Why?
|
| Basal Ganglia | 2 | 2004 | 546 | 0.250 |
Why?
|
| Anxiety | 6 | 2023 | 4297 | 0.250 |
Why?
|
| Brain Mapping | 6 | 2022 | 6669 | 0.240 |
Why?
|
| Relaxation | 1 | 2003 | 50 | 0.230 |
Why?
|
| Heroin Dependence | 1 | 2004 | 175 | 0.230 |
Why?
|
| Putamen | 1 | 2004 | 291 | 0.230 |
Why?
|
| Substance Withdrawal Syndrome | 2 | 2008 | 632 | 0.230 |
Why?
|
| Humans | 54 | 2023 | 744343 | 0.230 |
Why?
|
| Narcotics | 2 | 2007 | 343 | 0.230 |
Why?
|
| Excitatory Amino Acid Antagonists | 2 | 2004 | 449 | 0.220 |
Why?
|
| Depression | 3 | 2020 | 7766 | 0.220 |
Why?
|
| Corticosterone | 1 | 2004 | 310 | 0.220 |
Why?
|
| Decision Making | 2 | 2014 | 3887 | 0.220 |
Why?
|
| Receptors, GABA-A | 2 | 2004 | 627 | 0.210 |
Why?
|
| S-Adenosylmethionine | 1 | 2003 | 212 | 0.210 |
Why?
|
| Energy Metabolism | 3 | 2019 | 2899 | 0.210 |
Why?
|
| Hypothermia | 2 | 2001 | 189 | 0.200 |
Why?
|
| Verbal Learning | 2 | 2019 | 467 | 0.200 |
Why?
|
| Memory | 2 | 2022 | 2174 | 0.200 |
Why?
|
| Image Processing, Computer-Assisted | 5 | 2008 | 8949 | 0.200 |
Why?
|
| Hypnotics and Sedatives | 2 | 1999 | 1162 | 0.190 |
Why?
|
| Hippocampus | 3 | 2019 | 3675 | 0.190 |
Why?
|
| Methylphenidate | 1 | 2004 | 473 | 0.190 |
Why?
|
| Memory, Long-Term | 1 | 2020 | 64 | 0.180 |
Why?
|
| Rats, Sprague-Dawley | 11 | 2004 | 8301 | 0.180 |
Why?
|
| Atrophy | 2 | 2015 | 1583 | 0.180 |
Why?
|
| Temporal Lobe | 4 | 2022 | 1670 | 0.180 |
Why?
|
| Neurobiology | 1 | 2020 | 121 | 0.180 |
Why?
|
| Brain Diseases | 1 | 2008 | 1563 | 0.170 |
Why?
|
| Cognition | 5 | 2014 | 6770 | 0.160 |
Why?
|
| Creatine | 3 | 2021 | 421 | 0.160 |
Why?
|
| Analysis of Variance | 6 | 2011 | 6365 | 0.160 |
Why?
|
| Sexual Maturation | 1 | 2020 | 265 | 0.160 |
Why?
|
| Occipital Lobe | 1 | 2020 | 379 | 0.160 |
Why?
|
| Neuropsychological Tests | 5 | 2010 | 6993 | 0.150 |
Why?
|
| Diffusion Magnetic Resonance Imaging | 2 | 2007 | 2737 | 0.150 |
Why?
|
| Spirituality | 1 | 2021 | 405 | 0.150 |
Why?
|
| Sleep | 3 | 2014 | 4623 | 0.150 |
Why?
|
| Cocaine-Related Disorders | 3 | 2007 | 460 | 0.150 |
Why?
|
| Limbic System | 1 | 2019 | 426 | 0.150 |
Why?
|
| Adult | 25 | 2022 | 214055 | 0.140 |
Why?
|
| Rats | 12 | 2020 | 24260 | 0.140 |
Why?
|
| Central Nervous System Stimulants | 1 | 2004 | 1148 | 0.140 |
Why?
|
| Blood Volume | 2 | 2008 | 565 | 0.140 |
Why?
|
| Stress Disorders, Post-Traumatic | 3 | 2021 | 4266 | 0.130 |
Why?
|
| Age Factors | 7 | 2012 | 18370 | 0.130 |
Why?
|
| Gender Identity | 1 | 2020 | 688 | 0.130 |
Why?
|
| Regional Blood Flow | 4 | 2008 | 1525 | 0.120 |
Why?
|
| Behavior, Addictive | 1 | 2020 | 462 | 0.120 |
Why?
|
| Dose-Response Relationship, Drug | 6 | 2004 | 10943 | 0.120 |
Why?
|
| Models, Animal | 2 | 2020 | 2171 | 0.120 |
Why?
|
| Synaptic Transmission | 2 | 2014 | 1178 | 0.120 |
Why?
|
| Imagination | 1 | 2014 | 221 | 0.110 |
Why?
|
| Phosphocreatine | 2 | 2004 | 269 | 0.110 |
Why?
|
| Child | 8 | 2015 | 77709 | 0.110 |
Why?
|
| Sex Factors | 6 | 2021 | 10397 | 0.110 |
Why?
|
| Motor Activity | 4 | 2014 | 2714 | 0.110 |
Why?
|
| Maze Learning | 1 | 2014 | 478 | 0.110 |
Why?
|
| Respiration | 1 | 2019 | 1653 | 0.110 |
Why?
|
| Psychotherapy | 1 | 2021 | 1643 | 0.110 |
Why?
|
| Risk Factors | 6 | 2022 | 72290 | 0.100 |
Why?
|
| Case-Control Studies | 5 | 2021 | 21746 | 0.100 |
Why?
|
| Receptors, GABA | 1 | 2014 | 288 | 0.100 |
Why?
|
| Regression Analysis | 3 | 2014 | 6459 | 0.100 |
Why?
|
| Organophosphorus Compounds | 1 | 2013 | 215 | 0.100 |
Why?
|
| Risk | 1 | 2004 | 9687 | 0.100 |
Why?
|
| Stress, Psychological | 3 | 2022 | 4245 | 0.100 |
Why?
|
| Antidepressive Agents | 1 | 2003 | 2838 | 0.100 |
Why?
|
| Opioid-Related Disorders | 4 | 2007 | 2065 | 0.100 |
Why?
|
| Cocaine | 3 | 2002 | 1007 | 0.090 |
Why?
|
| Health Status | 1 | 2003 | 4034 | 0.090 |
Why?
|
| Antipsychotic Agents | 2 | 2019 | 3057 | 0.090 |
Why?
|
| Choline | 1 | 2011 | 493 | 0.090 |
Why?
|
| Suicidal Ideation | 1 | 2018 | 1248 | 0.080 |
Why?
|
| Family | 2 | 2010 | 3147 | 0.080 |
Why?
|
| Behavior, Animal | 3 | 2002 | 1881 | 0.080 |
Why?
|
| User-Computer Interface | 1 | 2014 | 1431 | 0.080 |
Why?
|
| Public Policy | 1 | 2012 | 572 | 0.080 |
Why?
|
| Cross-Sectional Studies | 3 | 2018 | 25043 | 0.080 |
Why?
|
| Adenosine Triphosphate | 2 | 2004 | 2025 | 0.080 |
Why?
|
| Nootropic Agents | 1 | 2008 | 160 | 0.080 |
Why?
|
| Mental Health | 1 | 2021 | 3019 | 0.080 |
Why?
|
| Body Temperature | 2 | 2001 | 777 | 0.070 |
Why?
|
| Reaction Time | 1 | 2014 | 2097 | 0.070 |
Why?
|
| Anisotropy | 2 | 2011 | 1265 | 0.070 |
Why?
|
| Bipolar Disorder | 2 | 2019 | 5027 | 0.070 |
Why?
|
| Psychomotor Performance | 1 | 2014 | 1901 | 0.070 |
Why?
|
| Administration, Oral | 2 | 2004 | 3913 | 0.070 |
Why?
|
| Visual Perception | 1 | 2014 | 1420 | 0.070 |
Why?
|
| Psychiatric Status Rating Scales | 3 | 2011 | 6038 | 0.060 |
Why?
|
| Cerebrovascular Circulation | 2 | 2006 | 2731 | 0.060 |
Why?
|
| Models, Statistical | 1 | 2019 | 5102 | 0.060 |
Why?
|
| Animals, Suckling | 2 | 2001 | 72 | 0.060 |
Why?
|
| Statistics as Topic | 1 | 2011 | 2373 | 0.060 |
Why?
|
| Cycloserine | 1 | 2005 | 113 | 0.060 |
Why?
|
| Vocabulary | 1 | 2005 | 169 | 0.060 |
Why?
|
| Prenatal Exposure Delayed Effects | 3 | 2002 | 2408 | 0.060 |
Why?
|
| Middle Aged | 15 | 2020 | 213383 | 0.060 |
Why?
|
| Disease Susceptibility | 1 | 2010 | 1782 | 0.060 |
Why?
|
| Diffusion Tensor Imaging | 3 | 2021 | 2305 | 0.060 |
Why?
|
| Caudate Nucleus | 1 | 2004 | 393 | 0.060 |
Why?
|
| Dominance, Cerebral | 1 | 2004 | 635 | 0.060 |
Why?
|
| Intelligence Tests | 1 | 2004 | 505 | 0.060 |
Why?
|
| Muscimol | 1 | 2002 | 69 | 0.050 |
Why?
|
| Animals | 14 | 2020 | 168757 | 0.050 |
Why?
|
| Caregivers | 1 | 2014 | 2094 | 0.050 |
Why?
|
| Substance Abuse Detection | 1 | 2004 | 283 | 0.050 |
Why?
|
| Demyelinating Diseases | 1 | 2004 | 354 | 0.050 |
Why?
|
| Phospholipids | 1 | 2004 | 784 | 0.050 |
Why?
|
| Swimming | 1 | 2001 | 206 | 0.050 |
Why?
|
| Reflex | 1 | 2002 | 365 | 0.050 |
Why?
|
| Speech | 1 | 2005 | 540 | 0.040 |
Why?
|
| Treatment Outcome | 3 | 2021 | 63114 | 0.040 |
Why?
|
| Dissociative Disorders | 1 | 2021 | 231 | 0.040 |
Why?
|
| Time Factors | 4 | 2019 | 40075 | 0.040 |
Why?
|
| Intelligence | 1 | 2004 | 920 | 0.040 |
Why?
|
| Rodentia | 1 | 2020 | 261 | 0.040 |
Why?
|
| Quality of Life | 1 | 2019 | 12804 | 0.040 |
Why?
|
| Conditioning, Classical | 1 | 2001 | 366 | 0.040 |
Why?
|
| Prospective Studies | 1 | 2022 | 53288 | 0.040 |
Why?
|
| Lactation | 1 | 2000 | 412 | 0.040 |
Why?
|
| Dopamine | 1 | 2004 | 1591 | 0.040 |
Why?
|
| Affect | 1 | 2004 | 1476 | 0.040 |
Why?
|
| Patient Compliance | 1 | 2007 | 2684 | 0.040 |
Why?
|
| Heart Rate | 2 | 2004 | 4091 | 0.030 |
Why?
|
| Drug Administration Schedule | 1 | 2003 | 4933 | 0.030 |
Why?
|
| Mental Disorders | 1 | 2014 | 6600 | 0.030 |
Why?
|
| Kinetics | 1 | 2001 | 6473 | 0.030 |
Why?
|
| Image Enhancement | 1 | 2004 | 2921 | 0.030 |
Why?
|
| Glycerylphosphorylcholine | 1 | 2013 | 25 | 0.030 |
Why?
|
| Reward | 1 | 2020 | 941 | 0.030 |
Why?
|
| Phosphatidylethanolamines | 1 | 2013 | 134 | 0.030 |
Why?
|
| Ethanolamines | 1 | 2013 | 158 | 0.030 |
Why?
|
| Phosphorylcholine | 1 | 2013 | 162 | 0.030 |
Why?
|
| Arousal | 1 | 1998 | 1165 | 0.030 |
Why?
|
| Environment | 1 | 1998 | 1124 | 0.030 |
Why?
|
| Wakefulness | 1 | 1998 | 1245 | 0.020 |
Why?
|
| Body Weight | 1 | 2001 | 4669 | 0.020 |
Why?
|
| Functional Laterality | 2 | 2008 | 2290 | 0.020 |
Why?
|
| Follow-Up Studies | 2 | 2019 | 39050 | 0.020 |
Why?
|
| Neural Pathways | 1 | 2021 | 2972 | 0.020 |
Why?
|
| Adaptation, Psychological | 1 | 2000 | 2576 | 0.020 |
Why?
|
| Diagnostic and Statistical Manual of Mental Disorders | 2 | 2007 | 1953 | 0.020 |
Why?
|
| Blood Pressure | 1 | 2004 | 8554 | 0.020 |
Why?
|
| Pregnancy Complications | 1 | 2002 | 2861 | 0.020 |
Why?
|
| Recurrence | 1 | 2020 | 8340 | 0.020 |
Why?
|
| Models, Biological | 1 | 2003 | 9583 | 0.020 |
Why?
|
| Severity of Illness Index | 2 | 2019 | 15540 | 0.020 |
Why?
|
| Color Perception | 1 | 2007 | 213 | 0.020 |
Why?
|
| Schizophrenia | 1 | 2005 | 6882 | 0.020 |
Why?
|
| Age of Onset | 1 | 2011 | 3271 | 0.020 |
Why?
|
| United States | 1 | 2012 | 69872 | 0.020 |
Why?
|
| Wounds and Injuries | 1 | 2017 | 2400 | 0.020 |
Why?
|
| Verbal Behavior | 1 | 2005 | 339 | 0.010 |
Why?
|
| Reading | 1 | 2007 | 558 | 0.010 |
Why?
|
| Pregnancy | 5 | 2002 | 29144 | 0.010 |
Why?
|
| Gadolinium | 1 | 2006 | 952 | 0.010 |
Why?
|
| Bottle Feeding | 1 | 2001 | 66 | 0.010 |
Why?
|
| Aged | 3 | 2019 | 163280 | 0.010 |
Why?
|
| Injections, Subcutaneous | 1 | 2002 | 666 | 0.010 |
Why?
|
| Cerebellum | 1 | 2006 | 1488 | 0.010 |
Why?
|
| Axons | 1 | 2005 | 1684 | 0.010 |
Why?
|
| Drug Therapy, Combination | 1 | 2005 | 6489 | 0.010 |
Why?
|
| Image Interpretation, Computer-Assisted | 1 | 2005 | 3327 | 0.010 |
Why?
|
| Logistic Models | 1 | 2007 | 13408 | 0.010 |
Why?
|
| Sensitivity and Specificity | 1 | 2007 | 14722 | 0.010 |
Why?
|
| Chronic Disease | 1 | 2006 | 9146 | 0.010 |
Why?
|
| Predictive Value of Tests | 1 | 2007 | 15076 | 0.010 |
Why?
|
| Double-Blind Method | 1 | 2005 | 12026 | 0.010 |
Why?
|
| Comorbidity | 1 | 2004 | 10388 | 0.010 |
Why?
|
| Aged, 80 and over | 1 | 2013 | 57776 | 0.000 |
Why?
|
| Disease Models, Animal | 1 | 2002 | 18029 | 0.000 |
Why?
|
| Retrospective Studies | 1 | 2002 | 77449 | 0.000 |
Why?
|
Concepts
(233)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(39)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_
Physical Neighbors
People whose addresses are nearby this person.
_